Literature DB >> 24503369

Regional specificity of synaptic plasticity deficits in a knock-in mouse model of DYT1 dystonia.

G Martella1, M Maltese2, R Nisticò3, T Schirinzi2, G Madeo2, G Sciamanna1, G Ponterio1, A Tassone4, G Mandolesi1, V Vanni4, M Pignatelli5, P Bonsi4, A Pisani6.   

Abstract

DYT1 dystonia is a movement disorder caused by a deletion in the C-terminal of the protein torsinA. It is unclear how torsinA mutation might disrupt cellular processes encoding motor activity, and whether this impairment occurs in specific brain regions. Here, we report a selective impairment of corticostriatal synaptic plasticity in knock-in mice heterozygous for Δ-torsinA (Tor1a(+/Δgag) mice) as compared to controls (Tor1a(+/+) mice). In striatal spiny neurons from Tor1a(+/Δgag) mice, high-frequency stimulation failed to induce long-term depression (LTD), whereas long-term potentiation (LTP) exhibited increased amplitude. Of interest, blockade of D2 dopamine receptors (D2Rs) increased LTP in Tor1a(+/+) mice to a level comparable to that measured in Tor1a(+/Δgag) mice and normalized the levels of potentiation across mouse groups. A low-frequency stimulation (LFS) protocol was unable to depotentiate corticostriatal synapses in Tor1a(+/Δgag) mice. Muscarinic M1 acetylcholine receptor (mAChR) blockade rescued plasticity deficits. Additionally, we found an abnormal responsiveness of cholinergic interneurons to D2R activation, consisting in an excitatory response rather than the expected inhibition, further confirming an imbalance between dopaminergic and cholinergic signaling in the striatum. Conversely, synaptic activity and plasticity in the CA1 hippocampal region were unaltered in Tor1a(+/Δgag) mice. Importantly, the M1 mAChR-dependent enhancement of hippocampal LTP was unaffected in both genotypes. Similarly, both basic properties of dopaminergic nigral neurons and their responses to D2R activation were normal. These results provide evidence for a regional specificity of the electrophysiological abnormalities observed and demonstrate the reproducibility of such alterations in distinct models of DYT1 dystonia.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cholinergic interneurons; D2 dopamine receptor; Dystonia; Long-term depression; Long-term potentiation; Muscarinic receptor antagonists; Striatum

Mesh:

Substances:

Year:  2014        PMID: 24503369     DOI: 10.1016/j.nbd.2014.01.016

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  29 in total

Review 1.  Using the shared genetics of dystonia and ataxia to unravel their pathogenesis.

Authors:  Esther A R Nibbeling; Cathérine C S Delnooz; Tom J de Koning; Richard J Sinke; Hyder A Jinnah; Marina A J Tijssen; Dineke S Verbeek
Journal:  Neurosci Biobehav Rev       Date:  2017-01-28       Impact factor: 8.989

Review 2.  Hyperkinetic disorders and loss of synaptic downscaling.

Authors:  Paolo Calabresi; Antonio Pisani; John Rothwell; Veronica Ghiglieri; Josè A Obeso; Barbara Picconi
Journal:  Nat Neurosci       Date:  2016-06-28       Impact factor: 24.884

3.  Structure of the Golgi apparatus is not influenced by a GAG deletion mutation in the dystonia-associated gene Tor1a.

Authors:  Sara B Mitchell; Sadahiro Iwabuchi; Hiroyuki Kawano; Tsun Ming Tom Yuen; Jin-Young Koh; K W David Ho; N Charles Harata
Journal:  PLoS One       Date:  2018-11-07       Impact factor: 3.240

Review 4.  Potential Therapeutic Application for Nicotinic Receptor Drugs in Movement Disorders.

Authors:  Maryka Quik; James T Boyd; Tanuja Bordia; Xiomara Perez
Journal:  Nicotine Tob Res       Date:  2019-02-18       Impact factor: 4.244

5.  Mouse model of rare TOR1A variant found in sporadic focal dystonia impairs domains affected in DYT1 dystonia patients and animal models.

Authors:  Srishti L Bhagat; Sunny Qiu; Zachary F Caffall; Yehong Wan; Yuanji Pan; Ramona M Rodriguiz; William C Wetsel; Alexandra Badea; Ute Hochgeschwender; Nicole Calakos
Journal:  Neurobiol Dis       Date:  2016-05-07       Impact factor: 5.996

6.  Strength of cholinergic tone dictates the polarity of dopamine D2 receptor modulation of striatal cholinergic interneuron excitability in DYT1 dystonia.

Authors:  Mariangela Scarduzio; Chelsea N Zimmerman; Karen L Jaunarajs; Qin Wang; David G Standaert; Lori L McMahon
Journal:  Exp Neurol       Date:  2017-06-03       Impact factor: 5.330

Review 7.  Striatal cholinergic dysfunction as a unifying theme in the pathophysiology of dystonia.

Authors:  K L Eskow Jaunarajs; P Bonsi; M F Chesselet; D G Standaert; A Pisani
Journal:  Prog Neurobiol       Date:  2015-02-17       Impact factor: 11.685

8.  Functional Genomic Analyses of Mendelian and Sporadic Disease Identify Impaired eIF2α Signaling as a Generalizable Mechanism for Dystonia.

Authors:  Joseph E Rittiner; Zachary F Caffall; Ricardo Hernández-Martinez; Sydney M Sanderson; James L Pearson; Kaylin K Tsukayama; Anna Y Liu; Changrui Xiao; Samantha Tracy; Miranda K Shipman; Patrick Hickey; Julia Johnson; Burton Scott; Mark Stacy; Rachel Saunders-Pullman; Susan Bressman; Kristina Simonyan; Nutan Sharma; Laurie J Ozelius; Elizabeth T Cirulli; Nicole Calakos
Journal:  Neuron       Date:  2016-12-08       Impact factor: 17.173

Review 9.  The neurobiological basis for novel experimental therapeutics in dystonia.

Authors:  Anthony M Downs; Kaitlyn M Roman; Simone A Campbell; Antonio Pisani; Ellen J Hess; Paola Bonsi
Journal:  Neurobiol Dis       Date:  2019-07-04       Impact factor: 5.996

10.  Trihexyphenidyl rescues the deficit in dopamine neurotransmission in a mouse model of DYT1 dystonia.

Authors:  Anthony M Downs; Xueliang Fan; Christine Donsante; H A Jinnah; Ellen J Hess
Journal:  Neurobiol Dis       Date:  2019-01-30       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.